BioSpace News Archive

Benchling, the leading life sciences cloud, today announced the launch of a digital solution for scientists to design, analyze, and develop complex RNA therapeutics in a unified R&D platform for the first time.

Know Labs, Inc. today announced it has been granted an additional patent for its Bio-RFID™ technology, growing its substantial patent portfolio to 57 issued and pending patents, an important milestone for the company.

Anna Biosciences today announces its entry in the fight against COVID-19 with the introduction of its immunotherapy platform, Syntem.

Genmab A/S (Nasdaq:GMAB)announced today that the European Commission (EC) has granted marketing authorization for the daratumumab subcutaneous (SC) formulation(daratumumab and hyaluronidase-fihj), known as DARZALEX® SCin the European Union, in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed systemiclight-chain (AL) amyloidosis.

Phio Pharmaceuticals Corp. today announced that it has rescheduled the Company’s fireside chat being hosted by H.C. Wainwright for July 12th.

Reference is made to the stock exchange notice published on 18 June 2021, at 08:00 CEST, regarding a share capital increase in relation to current and former board members’ exercise of in total 51,966 RSUs.

Gemini Therapeutics, Inc today announced initial data from its Phase 2a ReGAtta study of GEM103 as of May 2021 in patients with geographic atrophy (GA) secondary to dry AMD.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to five new employees.

Increasing investment in healthcare and improving healthcare infrastructure are key factors driving market growth.

Surging need for improving the efficiency of lab operations is a key factor influencing the global market growth.